Psychemedics

Psychemedics Dividend Yield

The Dividend Yield of Psychemedics (PMDI) as of Nov 4, 2026 is 9.98 %. In the previous year, Dividend Yield was 14.98 % — a change of -33.33% (lower).

Dividend Yield

9.98 %

YoY

-33.33%

Last updated:

Dividend Yield of Psychemedics is 2023 9.98 % . Dividend Yield of Psychemedics was 2022 14.98 % . It decreases by -33.33% lower compared to the previous year.

The Psychemedics Dividend Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Yield
Date
Dividend Yield
Jan 1, 2016
42.79 USD
Jan 1, 2017
42.79 USD
Jan 1, 2018
49.21 USD
Jan 1, 2019
51.35 USD
Jan 1, 2020
12.84 USD
Jan 1, 2021
3.57 USD
Jan 1, 2022
14.98 USD
Jan 1, 2023
9.98 USD
The Psychemedics Dividend Yield history
YEARDividend YieldYoY
9.98 %-33.33%
14.98 %+320.00%
3.57 %-72.22%
12.84 %-75.00%
51.35 %+4.35%
49.21 %+15.00%
42.79 %0.00%
42.79 %0.00%
42.79 %0.00%
42.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Dividend Yield of Psychemedics is 9.98 % in 2023.

Dividend Yield of Psychemedics changed from 14.98 % to 9.98 %, representing a -33.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Yield Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Psychemedics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Psychemedics

All Key Metrics — Psychemedics